Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

CSL Limited — CSL Limited

Tracked across 2 events · 111 articles · First seen Jun 26, 2026 · Last active Aug 07, 2026

Sentiment
-5
Attention
7
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 10
Regulatory
Impact: CSL Limited — CSL Limited is the marketer of Fluad, the rival flu vaccine allegedly disparaged by Sanofi's communication campaign, and could benefit from a more level playing field if the allegations are proven.
Jun 26, 2026 · 6 articles
7 -20
Regulatory
On August 5, 2026, the U.S. United States — Food and Drug Administration (FDA) approved Moderna's mFLUSIVA (mRNA-1010), the first mRNA-based seasonal influenza vaccine, for adults aged 50 and older. The approval covers traditional approval…
Impact: CSL Limited — CSL Limited, a flu vaccine maker, may see competitive pressure from the new mRNA vaccine.
Aug 05, 2026 · 105 articles
ERGEN INTELLIGENCE
Track CSL Limited — CSL Limited live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.